Found 7 matching trials
A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers. PHASE1 The main objective of this study is to evaluate the Effect of Food on the P...
Show More Location
The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College
Learn More & Join Trial
Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant ALK-Positive NSCLC PHASE4 ALK TKIs, particularly second- and third-generation ALK TKIs, have signific...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Umbrella Study Directed by Next Generation Sequencing PHASE2 This phase II, umbrella trial study directed by next generation sequencing ...
Show More Location
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology
Learn More & Join Trial
Expanded Access to Ensartinib for Participants With ALK+ NSCLC N/A This is an open-label, multicenter, intermediate-sized expanded access trea...
Show More Location
Stanford University
Learn More & Join Trial
The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors PHASE2 This study is designed to evaluate the efficacy and safety of a 2-year adju...
Show More Location
Multiple Locations
Learn More & Join Trial
A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions PHASE1 This is an open-label, Phase I single dose 2-part, crossover bioequivalence...
Show More Location
ICON - Early Development Services
Learn More & Join Trial
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer PHASE2 This randomized, active-controlled, multicenter, open-label, Phase II study...
Show More Location
Multiple Locations
Learn More & Join Trial